SAINTE-FOY, QUEBEC -- (MARKET WIRE) -- March 29, 2007 -- Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology drugs, today announced its results for the fiscal year ended December 31, 2006.
